Gonzales, Junior
Pirovano, Giacomo
Chow, Chun Yuen
de Souza Franca, Paula Demetrio
Carter, Lukas M.
Klint, Julie K.
Guru, Navjot
Lewis, Jason S.
King, Glenn F.
Reiner, Thomas
Funding for this research was provided by:
National Institutes of Health (CA232130, CA204441, CA008748)
australian national health and medical research council (APP1072113)
Australian National Health and Medical Research Council (APP1136889)
Ruth L. Kirschstein fellowship (EB025050)
Article History
Received: 20 February 2020
Accepted: 8 April 2020
First Online: 14 May 2020
Ethics approval
: All applicable international, national, and/or institutional guidelines for the care and use of animals were followed.
: All of the authors have read and approved the manuscript and possible conflict of interests are disclosed.
: T.R. is shareholder of Summit Biomedical Imaging, LLC, and paid consultant for Theragnostics, Inc. J.G., P.D.d.S.F., G.F.K., J.S.L., and T.R. filed a patent surrounding the use of fluorophores with Hs1a and Hsp1a.